CSTL — Castle Biosciences Share News
0.000.00%
Last trade - 00:00- $1.03bn
- $776.11m
- $344.23m
U.S. STOCKS ON THE MOVE-Golar LNG, gold miners, Big Tech
Castle Bio falls after cancer test fails to secure insurance coverage
Castle Biosciences Inc reports results for the quarter ended in March - Earnings Summary
U.S. RESEARCH ROUNDUP- Paramount Global, Sprout Social, Williams-Sonoma
Brief: Castle Biosciences Q1 Basic EPS USD -0.09
Castle Biosciences Inc expected to post a loss of 33 cents a share - Earnings Preview
Brief: Castle Biosciences Inc- On March 26 Entered Into A Loan And Security Agreement
Brief: Castle Biosciences Announces Updates To Its Board Of Directors
Castle Biosciences Inc reports results for the quarter ended in December - Earnings Summary
Brief: Castle Biosciences Inc Files For Mixed Shelf Offering Of Up To $300 Million - SEC Filing
Brief: Castle Biosciences Q4 Basic EPS USD -0.1
Castle Biosciences Inc expected to post a loss of 54 cents a share - Earnings Preview
Brief: Castle Biosciences Announces Preliminary Fourth Quarter And Full-Year 2023 Results
Brief: Real-World Evidence Confirms Idgenetix®-Guided Medication Management Significantly Improves Response And Remission Rates In Patients With Major Depressive Disorder
Brief: Castle Announces Early Exploratory Study Data For Potential Development Of A Complementary Test To Accompany Decisiondx-Um
Castle Biosciences Inc reports results for the quarter ended in September - Earnings Summary
Brief: Castle Biosciences Q3 Basic EPS USD -0.26
Castle Biosciences Inc expected to post a loss of 76 cents a share - Earnings Preview
Brief: Castle Biosciences to Present New Data on its TissueCypher Barrett’s Esophagus Test